| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V123479 | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium is a phospholipid with arachidonic acid linked at the sn-1 position. | |
|
V130418 | BMT-136088 | 1257213-96-9 | BMT-136088 is an LPAR1 antagonist. |
|
V112109 | BrP-LPA sodium | 944265-88-7 | BrP-LPA sodium is a pan-antagonist of lysophosphatidylcholine (LPA), exhibiting antagonistic activity against LPA1 (IC50 = 4520 nM), LPA2 (IC50 = 468 nM), LPA3, and LPA4. |
|
V3237 | CYM-5541 (ML249) | 945128-26-7 | CYM-5541 (also known as ML249) is a potent, selective, full, and allosteric agonist of the S1P3(Sphingosine 1-phosphate) receptor with EC50in the range of 72 to 132 nM. |
|
V94226 | GSK2018682 hydrochloride | 1034687-52-9 | GSK2018682 hydrochloride is an agonist for S1P1 and S1P5 receptors with pEC50 values of 7.7 and 7.2, respectively. |
|
V75460 | L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) | 105615-55-2 | L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) is an endogenous bioactive sphingolipid. |
|
V118880 | N-PTyrosine PA ammonium | 799268-45-4 | N-palmitoyltyrosine phosphate (N-palmitoyltyrosine phosphate) (ammonium) is a selective inhibitor of lysophosphatidyl acid receptors. |
|
V2583 | ONO-7300243 | 638132-34-0 | ONO-7300243 (ONO 7300243, ONO7300243)is a novel, potent and selective antagonist of LPA1(Lysophosphatidic Acid Receptor) with an IC50 of 160 nM. |
|
V144380 | RP-1859 | 1307869-95-9 | RP-1859 is a sphingosine-1-phosphate receptor (S1P) modulator. |
|
V102482 | S1P1 agonist 1 | 1220973-37-4 | S1P1 agonist 1 is a S1P1 agonist with immunomodulatory activity. |
|
V75451 | S1P1 agonist 4 | 1883345-11-6 | S1P1 agonist 4 performed better both in terms of potency (EC50 < 0.05 mg/kg) and predicted half-life in humans (t1/2 ∼ 5 days). |
|
V75448 | S1P1 agonist 6 hemicalcium | 2941310-03-6 | S1P1 agonist 6 hemicalcium (Compound I) is an S1P1 agonist. |
|
V75453 | S1P2 antagonist 1 | 2262402-83-3 | S1P2 antagonist 1 is an orally bioavailable anti-fibrotic S1P2 antagonist. |
|
V144462 | S1P5 receptor antagonist 1 | 1621065-22-2 | S1P5 receptor antagonist 1 is a selective, blood-brain barrier-crossing S1P5 receptor antagonist with an EC50 of 0.1 nM and a Ki of 4.4 nM. |
|
V144463 | S1PR1/S1PR5 agonist-1 | S1PR1/S1PR5 agonist-1 is an orally effective S1PR1 and S1PR5 agonist with EC50 values of 40.0 nM and 22.9 nM, respectively. | |
|
V144464 | S1PR5-IN-1 | 3107268-28-7 | S1PR5-IN-1 is a highly selective S1PR5 antagonist with good oral bioavailability. Its IC50 for human S1PR5 is 85.4 nM, and its Ka for human S1PR5 is 2.173 nM. |
|
V145024 | SLB1122168 free base | 2764877-95-2 | SLB1122168 free base is a Spinster homolog 2 (Spns2) inhibitor. |
|
V145229 | Spns2-IN-3 | 3035022-30-8 | Spns2-IN-3 is a synthetic pseudoceramide sphingolipid, similar to type II ceramides, and has a metastable layered structure. |
|
V84663 | TASP0277308 | 945725-50-8 | |
|
V146720 | UCM-05194 ammonium | UCM-05194 ammonium is a lysophosphatidylcholine receptor 1 (LPA1) agonist. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
